• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Biotechnology’s Role in Improving Stroke Outcomes

    CEO Spotlight: Marc Kikuchi

    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Novavax Submits EUA for Protein-based COVID-19 Vax Booster

    BeiGene, Ontada Enter Strategic Oncology Alliance

    AskBio Appoints Clinical Ops Executives

    SpectrumX Partners With UK Contract Manufacturer

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    SpectrumX Partners With UK Contract Manufacturer

    Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership

    Almac Invests $65M to Expand North American HQ

    Captor Therapeutics Selects CDMO for Clinical Trial Materials

    Catalent to Acquire Metrics Contract Services for $475M
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    UPS to Acquire Healthcare Logistics Provider Bomi Group

    Marken to Acquire Medical Courier Business of Cedra Express

    5 Key Features of Agile Pharmaceutical Packaging Supply Chains That Drive Results

    Novavax Expands Manufacturing Agreement with SK bioscience

    Lonza Continues to Lead the Market with Innovative Hard Empty Capsules
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Novavax Submits EUA for Protein-based COVID-19 Vax Booster

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth

    West Pharmaceutical Makes Strategic Investment in Latch Medical

    “3 Key Trends” with James Park

    Captor Therapeutics Selects CDMO for Clinical Trial Materials
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Chime Biologics Receives Commercial Manufacturing License

    Automation Is Key to Meeting Demands in Pharmacovigilance

    UBC Acquires Examoto

    Responding to Consumer Complaints While Working with CMOs

    WuXi Vaccines Receives GMP Certificate from HPRA
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Vector Partners Limited

    CMC Pharmaceuticals

    Kyongbo Pharmaceutical

    Qosina
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Vector Partners Limited

    CMC Pharmaceuticals

    Kyongbo Pharmaceutical

    Qosina
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Back Page

    Virtual Trials: Are they living up to their hype?

    This innovative approach is less costly, more patient-friendly, and delivers better quality data however, many stakeholders are still uncertain

    Virtual Trials: Are they living up to their hype?
    Related CONTENT
    • Eisai, Biogen Discontinue Phase III Alzheimer's Trials
    • FDA Extends CRADA with CluePoints
    • Embracing Risk-Based Monitoring: The Pivotal Role of Tools and Technologies
    • Caladrius, Cognate Ink Clinical Manufacturing Agreement
    • Virtual Trials: Are they living up to their hype?
    Josh Rose, VP R&D Global Strategy and Head of Virtual Trial Solutions, IQVIA09.16.19
    We’ve been talking about the value of virtual trials for a few years now. Are they delivering on their promise? The benefits are uncontestable—this innovative approach to clinical research is less costly, more patient-friendly, easier to recruit and delivers better quality data than a traditional site-based trial. However, many stakeholders are still uncertain about whether this trial model will work for them.

    Virtual trials are still relatively new, and in a highly regulated, risk-averse environment, embracing change can be difficult. But the truth is that virtual trials have been supported by regulators and proven to work in many scenarios, which should give stakeholders the confidence they need to get started.

    Lessons learned
    Executing virtual trials is complicated. This isn’t meant to discourage their use but to set appropriate expectations. Clinical trials by their nature are complex, and implementing virtual trials requires much more than simply deploying telemedicine services or giving patients a mobile app. They involve multiple platforms and devices, each of which captures and/or manages a unique data set that will follow its own cadence and construct. All of these platforms and workflows need to be seamlessly integrated and customized to accommodate the idiosyncrasies of that trial’s protocols, patient abilities and investigator needs. The personnel and patients involved in the trial also require training to use these tools while adhering to all rules and industry regulations.

    When vetting partners, sponsors should be certain their vendors have enough industry, technological and regulatory expertise to create a virtual trial environment that addresses all of these needs.

    Most virtual trials will follow a hybrid model. While a pure, 100 percent virtual trial is the ideal state from a cost-savings and efficiency standpoint, most trials have some on-site visits that can’t be fully eliminated. That’s OK. A hybrid model, which combines some site visits with virtual elements, still delivers time and cost savings while improving the patient experience and gives sponsors a low-risk jumping off point to become familiar with the virtual trial environment.

    By 2022, up to 40 percent of new trials may have some (or all) virtual elements, including telemedicine, home health visits and online surveys and questionnaires. By starting small and vetting the validity and reliability of existing virtual technologies, sponsors can gain confidence that future virtual deployments will deliver all of the promised results.

    Start early and make “virtual” part of the protocol planning. A virtual trial is about more than just selecting technology. It requires a different way of thinking about how investigators will engage with patients, collect data and demonstrate safety. By making it part of the trial planning process, sponsors ask the right questions from the outset, like how many physicals are really needed, whether endpoint data can be captured at home and whether wearable devices, telemedicine and home health nurses can replace on-site visits. When sponsors wait until after the trial protocol is approved to consider a virtual model option, many of these decisions have to be revisited, which adds costly delays to the process.

    Executive sponsorship is key. No matter how much the research team wants to test a virtual trial environment, until executive leadership is on-board, it won’t happen. They make the financial decisions, and they decide how much risk the organization is willing to take. Without their vocal support, others in the organization will be reluctant to engage in a new and unproven clinical research method. The good news is that once they are on-board, experience shows that these trials ramp up quickly, and that these leaders take an active role in engaging with regulators and working with CROs to ensure the deployment is a success.

    You need goals that are measurable and meaningful. As with any change-management effort, the only reason to do it is if it will solve a specific business problem or generate better results. There are many business and clinical benefits associated with virtual trials that can be easily measured, including accelerated recruiting, reduced costs and attrition, improved patient engagement and increased quality and quantity of data. All of these benefits help speed drug development and improve revenues. When you begin this journey with a business goal in mind, it becomes easier to win over executives and demonstrate the impact of this transformational approach to research.

    No two virtual trials are ever the same. Every clinical trial is unique, whether it’s conducted entirely through on-site visits, in a purely virtual format or somewhere in between. And while every virtual trial will provide sponsors with valuable insights into how to operate in the virtual environment, each new trial design will require a customized, strategic approach. The key is to keep an open mind, to capture lessons learned from the past and to work with partners who have deep technical, clinical and regulatory knowledge to ensure every trial meets the highest expectations for safety, quality, compliance and financial results. 
    Related Searches
    • Clinical Trial
    • patients
    • Development
    • clinical research
    Suggested For You
    Eisai, Biogen Discontinue Phase III Alzheimer Eisai, Biogen Discontinue Phase III Alzheimer's Trials
    FDA Extends CRADA with CluePoints FDA Extends CRADA with CluePoints
    Embracing Risk-Based Monitoring: The Pivotal Role of Tools and Technologies  Embracing Risk-Based Monitoring: The Pivotal Role of Tools and Technologies
    Caladrius, Cognate Ink Clinical Manufacturing Agreement Caladrius, Cognate Ink Clinical Manufacturing Agreement
    Virtual Trials: Are they living up to their hype? Virtual Trials: Are they living up to their hype?
    Bayer Bayer
    Sanofi Sanofi
    Novartis Novartis
    CDMO Great Bay Bio Founded CDMO Great Bay Bio Founded
    Eisai Inc. Adds Expert Alzheimer Eisai Inc. Adds Expert Alzheimer's Executives
    Pushing Research to Its Full Potential Pushing Research to Its Full Potential
    Evolution Research Acquires Finger Lakes Clinical Research Evolution Research Acquires Finger Lakes Clinical Research
    LabConnect Appoints Medical Director LabConnect Appoints Medical Director

    Related Breaking News

    • Drug Development | Trials & Filings
      Eisai, Biogen Discontinue Phase III Alzheimer

      Eisai, Biogen Discontinue Phase III Alzheimer's Trials

      Data Safety Monitoring Board recommended to discontinue trials due to unfavorable risk-benefit ratio
      09.13.19

    • Breaking News | Clinical Trials | Industry News | Inspections | QA/QC
      FDA Extends CRADA with CluePoints

      FDA Extends CRADA with CluePoints

      Aims to further explore a data-driven approach to quality oversight in clinical trials
      09.11.19

    • Clinical Trials | Drug Development | Information Technology
      Embracing Risk-Based Monitoring: The Pivotal Role of Tools and Technologies

      Embracing Risk-Based Monitoring: The Pivotal Role of Tools and Technologies

      Opportunities to improve the implementation of risk-based monitoring (RBM) in clinical investigations
      Jonathan Andrus, Chief Business Officer, Clinical Ink 08.15.19


    • Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
      Caladrius, Cognate Ink Clinical Manufacturing Agreement

      Caladrius, Cognate Ink Clinical Manufacturing Agreement

      For phase 3 trial of CLBS14 in no-option refractory disabling angina
      08.12.19

    • Clinical Trials | Drug Development | Information Technology
      Virtual Trials: Are they living up to their hype?

      Virtual Trials: Are they living up to their hype?

      This innovative approach is less costly, more patient-friendly, and delivers better quality data however, many stakeholders are still uncertain
      Josh Rose, VP R&D Global Strategy and Head of Virtual Trial Solutions, IQVIA 07.25.19

    Loading, Please Wait..
    Trending
    • Thermo Fisher Expands NY Cell Culture Media Manufacturing Site
    • Pfizer, Neurocrine Terminate Collaboration
    • Almac Invests $65M To Expand North American HQ
    • Catalent To Acquire Metrics Contract Services For $475M
    • Novavax Submits EUA For Protein-based COVID-19 Vax Booster
    Breaking News
    • Novavax Submits EUA for Protein-based COVID-19 Vax Booster
    • BeiGene, Ontada Enter Strategic Oncology Alliance
    • AskBio Appoints Clinical Ops Executives
    • GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    • SpectrumX Partners With UK Contract Manufacturer
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Biotechnology’s Role in Improving Stroke Outcomes
    • CEO Spotlight: Marc Kikuchi
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    What are you Reading this Week?
    SONGWON Industrial Group Reports Strong Q2 Financial Results
    PPG Completes COLORFUL COMMUNITIES Project for Boys & Girls Clubs of Greater Houston
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Spartech Promotes Three Staff Members
    Elisabeth Lackner Named Chief Scientific Officer at Element Materials Technology
    Natech Plastics Purchases Three New Injection Molding Machines
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Novavax Submits EUA for Protein-based COVID-19 Vax Booster
    BeiGene, Ontada Enter Strategic Oncology Alliance
    AskBio Appoints Clinical Ops Executives
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Body Shop Encourages Young People to Vote
    Weekly Recap: Howard Kaneff Dies, Keys Soulcare Adds SPF Skincare Offering & More
    Arkay Chairman Emeritus Howard Kaneff Has Died
    Happi

    Latest Breaking News From Happi

    In-Cosmetics Asia Returns to Bangkok to Deliver Look at Market Trends and Ingredient Innovations
    Perfect Corp. AI Skin Analysis Beauty SaaS Brand Console is Now HIPAA-Compliant
    Black-Owned Dinobi Detergent Uses Plant-Based Green Ingredients
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Printing Ink Primer, Zeller+Gmelin Lead This Week’s News Stories
    Heidelberg Enjoys Successful Start to 2022-23 Fiscal Year
    Mimaki Announces New LATAM Website
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Pro Label Inc. installs first Mark Andy DSiQ hybrid press
    Gallus launches Gallus One inkjet label press
    Esko, Constantia Flexibles announce acquisitions and more
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Essity Switches to Recyclable Packs for Feminine Pads, FTC Sues PPE Maker on False Origin Claims & More
    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Bioventus Achieves Strong Growth in Q2 2022
    Bone Void Fillers Market Growing at 6%
    ODT's Most-Read Stories This Week—Aug. 13
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: ALTANA, Universal Display and Emerson Top This Week’s Stories
    eMagin Corporation Announces 2Q 2022 Results
    Zebra Technologies’ Emission Reduction Targets Validated by SBTi

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login